Twist Bioscience Appoints Drug Discovery Leader Melissa Starovasnik, Ph.D., to Board of Directors
August 6, 2021
SOUTH SAN FRANCISCO, Calif. -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced it appointed Melissa Starovasnik, Ph.D. to its board of directors. Dr. Starovasnik most recently served as Senior Scientific Advisor, Research at Genentech, Inc. and brings nearly [...]
August 5, 2021
CAMBRIDGE, Mass. & SOUTH SAN FRANCISCO, Calif. -- Ultivue, Inc. and Fluidigm Corporation (Nasdaq:FLDM) today announced a co-marketing agreement in which the companies will offer customers a comprehensive portfolio of workflow solutions for biomarker discovery and drug development. Ultivue, a leader in advancing precision medicine solutions by accelerating tissue biomarker discovery and validation develops unique [...]
August 5, 2021
Applied Food Diagnostics, Inc., a food science solutions company, is pleased to announce the Cannabis Pathogen Screen test kit developed for the needs of cannabis diagnostic laboratories. The Cannabis Pathogen Screen (CPS) test provides detection of two pathogens and four potentially hazardous molds: Aspergillus flavus, A. fumigatus, A. niger, and A. terreus, in cannabis and cannabis-infused products in one [...]
August 5, 2021
Advanced Instruments to Acquire Solentim, a Trusted Global Leader in Cell Imaging for Cell Line Development and Clone Characterization NORWOOD, Mass. – Advanced Instruments, a leading manufacturer of analytical instruments and services for bioprocessing, today announced the execution of a definitive agreement to acquire Solentim, a trusted global leader of solutions for the isolation and characterization [...]
August 5, 2021
Objective of Agreement is Comprehensive Portfolio for Biomarker Discovery and Drug Development SOUTH SAN FRANCISCO, Calif. -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced a co-marketing agreement with Ultivue, Inc., under which the companies will offer a comprehensive portfolio of solutions for [...]
HTG’s New HTG Transcriptome Panel Launched with Commercial Availability in the U.S. and Europe
August 5, 2021
HTG Transcriptome Panel designed to measure approximately 20,000 mRNA targets using the HTG EdgeSeq technology Intended to serve as one of the technological cornerstones for the recently announced HTG Therapeutics Business Unit A third white paper highlighting the HTG Transcriptome Panel’s design, performance, and broad applicability now available TUCSON, Ariz. -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a [...]
August 5, 2021
Collaboration Focusing on Advancing CRO Capabilities in Drug Development Utilizing the Hyperion Imaging SystemSOUTH SAN FRANCISCO, Calif. -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced a collaboration and co-marketing agreement with ImaBiotech for service offerings and product development for Imaging Mass Cytometry™ [...]
Christopher Reidy Announces Intent to Retire from BD
August 5, 2021
Reidy Will Join Board of Directors of Planned Diabetes Care Spinoff FRANKLIN LAKES, N.J. -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Christopher Reidy, 64, executive vice president, chief financial officer (CFO) and chief administrative officer (CAO), has informed the company of his intent to retire [...]
August 5, 2021
NORCROSS, GA. – Omega Bio-tek, a leading nucleic acid purification kit manufacturer, releases an automation-ready, prefilled DNA extraction kit for magnetic processors to purify DNA faster and easier than before. The convenient Mag-Bind® Blood & Tissue DNA HDQ Prefilled 96 Kit comes prefilled with magnetic beads, reagent plates, and tip combs and aims to simplify [...]
August 5, 2021
DeepMatter (AIM: DMTR), the AIM-quoted company focusing on digitising chemistry, has commenced a project with the University of Cambridge’s Innovation Centre in Digital Molecular Technologies (iDMT), an open innovation research centre co-funded by the University of Cambridge, AstraZeneca, Shionogi, and the European Regional Development Fund. DeepMatter will provide its DigitalGlassware® platform to iDMT as part of the [...]

